{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T21:44:28Z","timestamp":1781041468473,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.neuint.2014.10.005","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T19:45:13Z","timestamp":1415043913000},"page":"57-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Small-molecule inhibitors at the PSD-95\/nNOS interface attenuate MPP+-induced neuronal injury through Sirt3 mediated inhibition of mitochondrial dysfunction"],"prefix":"10.1016","volume":"79","author":[{"given":"Wei","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai-Shun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Bo","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Yu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2014.10.005_bib0010","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1126\/science.1072873","article-title":"Treatment of ischemic brain damage by perturbing NMDA receptor\u2013PSD-95 protein interactions","volume":"298","author":"Aarts","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuint.2014.10.005_bib0015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0006-2952(03)00297-1","article-title":"Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors","volume":"66","author":"Aarts","year":"2003","journal-title":"Biochem. Pharmacol"},{"key":"10.1016\/j.neuint.2014.10.005_bib0020","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/awr028","article-title":"Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias","volume":"134","author":"Ahmed","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2014.10.005_bib0025","doi-asserted-by":"crossref","first-page":"14447","DOI":"10.1073\/pnas.0803790105","article-title":"A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis","volume":"105","author":"Ahn","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuint.2014.10.005_bib0030","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1038\/onc.2011.37","article-title":"SirT3 suppresses hypoxia inducible factor 1alpha and tumor growth by inhibiting mitochondrial ROS production","volume":"30","author":"Bell","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.neuint.2014.10.005_bib0035","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ygeno.2004.11.003","article-title":"A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages","volume":"85","author":"Bellizzi","year":"2005","journal-title":"Genomics"},{"key":"10.1016\/j.neuint.2014.10.005_bib0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0278-5846(01)00237-8","article-title":"Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment","volume":"26","author":"Calon","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2014.10.005_bib0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1083\/jcb.200407024","article-title":"The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death","volume":"168","author":"Cao","year":"2005","journal-title":"J. Cell Biol"},{"key":"10.1016\/j.neuint.2014.10.005_bib0050","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s11064-011-0691-z","article-title":"Protective effects of mGluR5 positive modulators against traumatic neuronal injury through PKC-dependent activation of MEK\/ERK pathway","volume":"37","author":"Chen","year":"2012","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.neuint.2014.10.005_bib0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2011.10.451","article-title":"Down-regulation of Homer1b\/c attenuates glutamate-mediated excitotoxicity through endoplasmic reticulum and mitochondria pathways in rat cortical neurons","volume":"52","author":"Chen","year":"2012","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.neuint.2014.10.005_bib0060","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3892\/ijmm.2011.870","article-title":"The selective mGluR5 agonist CHPG protects against traumatic brain injury in vitro and in vivo via ERK and Akt pathway","volume":"29","author":"Chen","year":"2012","journal-title":"Int. J. Mol. Med"},{"key":"10.1016\/j.neuint.2014.10.005_bib0065","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/j.cellsig.2013.09.004","article-title":"Homer1 knockdown protects dopamine neurons through regulating calcium homeostasis in an in vitro model of Parkinson's disease","volume":"25","author":"Chen","year":"2013","journal-title":"Cell. Signal"},{"key":"10.1016\/j.neuint.2014.10.005_bib0070","doi-asserted-by":"crossref","first-page":"e55601","DOI":"10.1371\/journal.pone.0055601","article-title":"Protective effects of SKF-96365, a non-specific inhibitor of SOCE, against MPP+-induced cytotoxicity in PC12 cells: potential role of Homer1","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.neuint.2014.10.005_bib0075","article-title":"Amantadine in Parkinson's disease","author":"Crosby","year":"2003","journal-title":"Cochrane Database Syst. Rev"},{"issue":"2","key":"10.1016\/j.neuint.2014.10.005_bib0080","article-title":"Amantadine for dyskinesia in Parkinson's disease","author":"Crosby","year":"2003","journal-title":"Cochrane Database Syst. Rev"},{"key":"10.1016\/j.neuint.2014.10.005_bib0085","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3892\/ijmm.2014.1876","article-title":"Sirt3 attenuates hydrogen peroxide-induced oxidative stress through the preservation of mitochondrial function in HT22 cells","volume":"34","author":"Dai","year":"2014","journal-title":"Int. J. Mol. Med"},{"key":"10.1016\/j.neuint.2014.10.005_bib0090","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2014.10.005_bib0095","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/mds.1112","article-title":"Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study","volume":"16","author":"Del Dotto","year":"2001","journal-title":"Mov. Disord"},{"key":"10.1016\/j.neuint.2014.10.005_bib0100","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","article-title":"Parkinson disease: from pathology to molecular disease mechanisms","volume":"62","author":"Dexter","year":"2013","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.neuint.2014.10.005_bib0105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1212\/WNL.62.1.158","article-title":"Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment","volume":"62","author":"Diguet","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2014.10.005_bib0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-5793(93)80498-J","article-title":"Assay conditions for the mitochondrial NADH:coenzyme Q oxidoreductase","volume":"332","author":"Estornell","year":"1993","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuint.2014.10.005_bib0115","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1038\/emboj.2012.170","article-title":"Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences","volume":"31","author":"Exner","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2014.10.005_bib0120","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1476-5381.2009.00300.x","article-title":"Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents","volume":"158","author":"Florio","year":"2009","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.neuint.2014.10.005_bib0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","article-title":"Mammalian sirtuins: biological insights and disease relevance","volume":"5","author":"Haigis","year":"2010","journal-title":"Annu. Rev. Pathol"},{"key":"10.1016\/j.neuint.2014.10.005_bib0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2004.04.001","article-title":"Rationale for and use of NMDA receptor antagonists in Parkinson's disease","volume":"102","author":"Hallett","year":"2004","journal-title":"Pharmacol. Ther"},{"key":"10.1016\/j.neuint.2014.10.005_bib0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism","volume":"51","author":"Hauser","year":"2013","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.neuint.2014.10.005_bib0140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0166-2236(96)01033-8","article-title":"The postsynaptic density at glutamatergic synapses","volume":"20","author":"Kennedy","year":"1997","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuint.2014.10.005_bib0145","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1083\/jcb.136.3.669","article-title":"GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95\/SAP90 family of channel clustering molecules","volume":"136","author":"Kim","year":"1997","journal-title":"J. Cell Biol"},{"key":"10.1016\/j.neuint.2014.10.005_bib0150","doi-asserted-by":"crossref","first-page":"e14731","DOI":"10.1371\/journal.pone.0014731","article-title":"Neuronal Sirt3 protects against excitotoxic injury in mouse cortical neuron culture","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuint.2014.10.005_bib0155","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1242\/jcs.03443","article-title":"A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases","volume":"120","author":"Mandemakers","year":"2007","journal-title":"J. Cell Sci"},{"key":"10.1016\/j.neuint.2014.10.005_bib0160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00002512-200320050-00006","article-title":"Glutamate receptors and Parkinson's disease: opportunities for intervention","volume":"20","author":"Marino","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.neuint.2014.10.005_bib0165","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1089\/ars.2011.4033","article-title":"Toxin models of mitochondrial dysfunction in Parkinson's disease","volume":"16","author":"Martinez","year":"2012","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.neuint.2014.10.005_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20070140","article-title":"Sirtuins in mammals: insights into their biological function","volume":"404","author":"Michan","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2014.10.005_bib0175","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mds.10107","article-title":"Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat","volume":"17","author":"Nash","year":"2002","journal-title":"Mov. Disord"},{"key":"10.1016\/j.neuint.2014.10.005_bib0180","doi-asserted-by":"crossref","first-page":"13653","DOI":"10.1073\/pnas.222538099","article-title":"SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria","volume":"99","author":"Onyango","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuint.2014.10.005_bib0185","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1523\/JNEUROSCI.1119-12.2013","article-title":"Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis","volume":"33","author":"Parone","year":"2013","journal-title":"J. Neurosci"},{"key":"10.1016\/j.neuint.2014.10.005_bib0190","doi-asserted-by":"crossref","first-page":"267120","DOI":"10.1100\/2012\/267120","article-title":"Distribution of extrasynaptic NMDA receptors on neurons","volume":"2012","author":"Petralia","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.neuint.2014.10.005_bib0195","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mcn.2012.08.002","article-title":"Mouse models of Parkinson's disease associated with mitochondrial dysfunction","volume":"55","author":"Pickrell","year":"2013","journal-title":"Mol. Cell. Neurosci"},{"key":"10.1016\/j.neuint.2014.10.005_bib0200","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.cmet.2010.11.015","article-title":"Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation","volume":"12","author":"Qiu","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.neuint.2014.10.005_bib0205","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.bbapap.2009.09.015","article-title":"Sirtuin regulation in calorie restriction","volume":"1804","author":"Qiu","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2014.10.005_bib0210","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1212\/01.WNL.0000058760.13152.1A","article-title":"Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment","volume":"60","author":"Ravina","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2014.10.005_bib0215","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0896-6273(01)00339-7","article-title":"Regulation of dendritic spine morphology and synaptic function by Shank and Homer","volume":"31","author":"Sala","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2014.10.005_bib0220","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1126\/science.284.5421.1845","article-title":"Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein","volume":"284","author":"Sattler","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuint.2014.10.005_bib0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson's disease","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurol"},{"issue":"Suppl. 3","key":"10.1016\/j.neuint.2014.10.005_bib0230","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1016\/S1353-8020(08)70021-X","article-title":"Mechanisms of neurodegeneration in idiopathic Parkinson's disease","volume":"13","author":"Schulz","year":"2007","journal-title":"Parkinsonism Relat. Disord"},{"key":"10.1016\/j.neuint.2014.10.005_bib0235","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1242\/jcs.114.7.1251","article-title":"The postsynaptic NMDA-receptor\u2013PSD-95 signaling complex in excitatory synapses of the brain","volume":"114","author":"Sheng","year":"2001","journal-title":"J. Cell Sci"},{"key":"10.1016\/j.neuint.2014.10.005_bib0240","first-page":"2758","article-title":"Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice","volume":"119","author":"Sundaresan","year":"2009","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.neuint.2014.10.005_bib0245","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1093\/emboj\/18.22.6349","article-title":"Apoptosis driven by IP(3)-linked mitochondrial calcium signals","volume":"18","author":"Szalai","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2014.10.005_bib0250","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nbd.2013.04.015","article-title":"Neuroglobin overexpression inhibits oxygen-glucose deprivation-induced mitochondrial permeability transition pore opening in primary cultured mouse cortical neurons","volume":"56","author":"Yu","year":"2013","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.neuint.2014.10.005_bib0255","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/nm.2245","article-title":"Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95","volume":"16","author":"Zhou","year":"2010","journal-title":"Nat. Med"},{"key":"10.1016\/j.neuint.2014.10.005_bib0260","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.54.8.1583","article-title":"A multicenter randomized controlled trial of remacemide hydrochloride as monotherapy for PD","volume":"54","year":"2000","journal-title":"Neurology"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018614002216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018614002216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T23:51:41Z","timestamp":1650498701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018614002216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":51,"alternative-id":["S0197018614002216"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2014.10.005","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small-molecule inhibitors at the PSD-95\/nNOS interface attenuate MPP+-induced neuronal injury through Sirt3 mediated inhibition of mitochondrial dysfunction","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2014.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}